SCHEMBL941048

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL940006	0.92	HDAC11 (0.39)	FGFR1RETTBK1RIPK1KDR
	SCHEMBL940266	0.91	PTGES (0.38)	FGFR1RETTBK1RIPK1KDR
	SCHEMBL939855	0.91	FGFR1 (0.46)	FGFR1RETTBK1RIPK1KDR
	SCHEMBL939309	0.90	AURKB (0.38)	FGFR1RETTBK1RIPK1KDR
	SCHEMBL941158	0.89	RAF1 (0.39)	FGFR1RETTBK1KDRPTGES
	SCHEMBL940838	0.89	PTGES (0.36)	FGFR1RETTBK1RIPK1KDR
	SCHEMBL940283	0.89	FGFR1 (0.36)	FGFR1RETTBK1CCNT1FLT3
	SCHEMBL940095	0.89	AURKB (0.40)	FGFR1RETTBK1KDRMAPK14
	SCHEMBL939356	0.89	POLB (0.43)	FGFR1RETTBK1RIPK1KDR
	SCHEMBL940272	0.89	MEN1 (0.43)	FGFR1RETTBK1CCNT1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.